Karyopharm Therapeutics Inc. (Nasdaq: KPTI) widened second quarter losses to 92 cents per share from 55 cents per share in the year ago period. Shares of the pharmaceutical firm plummeted $8.61 to close at $13.44.
Karyopharm Therapeutics widens losses
August 10, 2015 at 10:40 AM EDT